In China, a single grey hair is still treated as a diagnosis
South China Morning Post reporting on white-hair plucking taboos reveals a consumer market that treats greying as a medical problem — and a window onto how Chinese spending actually works in 2026.

A single strand of grey in the wrong light is enough, in many Chinese households, to set off a small but determined campaign: the kitchen cupboard is raided for black sesame and walnuts, an appointment is made at the salon, and the offending hair is plucked, dyed, or smothered in tonic. The reaction, recently documented by the South China Morning Post, is a reminder that in China greying is rarely treated as a routine fact of life. It is read as a signal — of exhaustion, of deficiency, of a body out of balance — and, in a market now saturated with cosmetic, dietary, and traditional answers, as a problem to be addressed promptly and often expensively.
The SCMP's reporting frames the issue as cultural, but the pattern is also economic: a Chinese consumer culture that has, over two decades, learned to spend aggressively on personal appearance, supplements, and preventive health treats visible aging as a category of consumption. To understand why plucking a white hair can feel like a small medical emergency, it helps to trace the inheritance — a traditional framework in which grey hair is a symptom — and the modern consumer market that has organised itself around treating it.
What traditional Chinese medicine actually says about grey hair
In the inherited framework of traditional Chinese medicine, greying is not a neutral biological event. It is read as a sign that the body's deeper reserves are flagging. The classical associations — kidney essence depletion, blood deficiency, sluggish qi — map greying onto an internal economy in which colour is a visible readout of resources the body has spent. The remedy logic that follows is dietary: black sesame, walnuts, Chinese yam, he shou wu (Polygonum multiflorum), and a wider pharmacopeia of "darkening" foods and herbs, ingested over weeks or months to push the colour back into the follicle.
The SCMP report documents how strongly this logic persists in everyday practice. Remedies are passed down within families, the seven-for-one myth — that pulling one white hair summons seven in its place — circulates as folk wisdom, and greying at a young age is discussed in language usually reserved for an illness. The cultural weight here is not incidental. It is the substrate that modern marketers, supplement-makers, and salons have learned to work with rather than against, and it gives Chinese consumers a ready-made vocabulary for talking about what would, in much of the West, be dismissed as a cosmetic preference.
Generationally, the picture is uneven. Older Chinese consumers, who came of age during the early reform decades, are likelier to default to the dietary remedy and the family prescription. Younger urban consumers are more likely to combine the TCM diagnosis with a modern treatment — dye, supplement, in-clinic procedure — and to discuss the problem in the language of self-optimisation that has become common across Chinese social media. Both cohorts, though, accept the underlying premise: grey hair is a problem to be solved, not a fact to be worn.
The consumer market that grew up around the diagnosis
If traditional Chinese medicine gives Chinese consumers a reason to act, modern retail gives them the means. China's beauty-and-personal-care market has grown into one of the world's largest, and hair dye, scalp tonics, and TCM-derived supplements form a recognisable cluster inside it. The category is no longer fringe. Major e-commerce platforms host dedicated aisles of "anti-grey" shampoos, capsules, and tinctures; traditional pharmacies sell he shou wu and related preparations; high-street salons compete on the speed and naturalness of their greying coverage.
The price points are wide. A consumer can spend a few yuan on black sesame paste from a supermarket or several hundred on a clinical-style scalp treatment at a chain salon. The economic gravity of the category is one reason that multinationals, domestic Chinese brands, and TCM-pharma incumbents all compete for share — and one reason that the framing of greying as pathology, inherited from TCM, has been commercially amplified rather than retired. The category is also one of the clearer cases in which an "old" Chinese framework and a "new" Chinese consumer economy are not in tension but in productive alignment.
The breadth of the market also reflects the trust consumers place in the underlying diagnosis. Where a Western consumer might treat early greying as a vanity concern to be addressed with a box of dye, the Chinese framing encourages a more active intervention — not just colouring the symptom but addressing the cause, whether that cause is framed in TCM terms (kidney essence, blood flow) or in modern nutritional terms (B-vitamin deficiency, oxidative stress). The market, in other words, sells both the diagnosis and the cure, and the diagnosis travels.
What this tells us about how Chinese consumers spend
The white-hair story is small, but it is a useful lens onto a broader pattern. Chinese consumer culture in 2026 is sophisticated, demanding, and willing to spend on personal maintenance in ways that would have been unfamiliar a generation ago. The same engine is visible in adjacent categories. In the auto market, Chinese-made vehicles from both domestic champions and foreign assemblers are now selling at sustained pace, with one recent market reading showing Tesla's China-made EV sales up 39.4% year-on-year in May — the seventh straight month of growth, according to a market-data post circulating on X.
The connection is not that consumers are buying the same products but that they are buying on the same terms: visible modernisation, performance, and a willingness to pay a premium for a category of goods that signals, to the buyer and to others, an upgraded version of everyday life. Grey hair and electric vehicles sit at very different price points, but the cultural operation underneath is the same — Chinese consumers have come to expect that ordinary problems (ageing, transport) are markets worth investing in, and Chinese and foreign firms alike have organised their offerings around that expectation.
It is also a useful corrective to lazy Western framings of the Chinese consumer as either price-driven or imitative. The same buyer who, twenty years ago, would have been assumed to copy Western cosmetics shelves is now driving category innovation in scalp care, TCM-derived nutraceuticals, and ingestible beauty, with both domestic and multinational firms competing to read local demand correctly. The growth in Chinese-made EV sales, on the same logic, is being underwritten by a consumer who has become harder to read from outside and more expensive to lose.
The stakes — and what the sources don't tell us
The persistence of TCM logic inside a hyper-modern consumer market raises a question that the SCMP piece gestures at but does not fully answer: who captures the upside as China's population ages? The country is greying demographically at a speed that has no rich-world precedent, and the cohort most likely to worry about visible greying is also the cohort with the most disposable income. Domestic TCM brands, multinationals selling clinically-positioned cosmetics, and grey-market e-commerce sellers are all in the race. The competing framings — TCM as heritage science, TCM as folk belief, grey hair as a medical problem, grey hair as a cosmetic preference — will not resolve themselves; they are part of a much larger negotiation between China's traditional frameworks and its modern consumer economy.
What the available reporting does not capture, and what this article cannot make firmer than it is, is the size of the anti-greying market in yuan, the share captured by domestic versus foreign brands, or the regulatory posture of Chinese authorities toward TCM-derived supplements marketed for greying. Those numbers are out of scope for a piece anchored in cultural reportage. The broader point survives: in China, the boundary between health and consumption is drawn differently than in the West, and the most mundane signs of aging sit inside that boundary.
This piece anchors culture-desk coverage in the South China Morning Post's reporting on a small but telling slice of Chinese consumer life, and reads it alongside a market datapoint on Chinese-made EV sales to make a larger point about how Chinese spending operates in 2026.
Wire provenance
This editorial synthesis draws on the following public wire/social posts:
- https://en.wikipedia.org/wiki/Traditional_Chinese_medicine
- https://en.wikipedia.org/wiki/Polygonum_multiflorum
- https://en.wikipedia.org/wiki/Demographics_of_China